Spatial and temporal correlation in progressive degeneration of neurons and astrocytes in contusion-induced spinal cord injury by Kyoung-Jin Min et al.
RESEARCH Open Access
Spatial and temporal correlation in progressive
degeneration of neurons and astrocytes in
contusion-induced spinal cord injury
Kyoung-Jin Min1†, Hey-Kyeong Jeong1,2†, Beomsue Kim1, Dong Hoon Hwang3, Hae Young Shin2,3,
An Tran Nguyen1, Jong-hyeon Kim1,2, Ilo Jou1,2,5, Byung G Kim2,3,4,5 and Eun-hye Joe1,2,4,5*
Abstract
Background: Traumatic spinal cord injury (SCI) causes acute neuronal death followed by delayed secondary
neuronal damage. However, little is known about how microenvironment regulating cells such as microglia,
astrocytes, and blood inflammatory cells behave in early SCI states and how they contribute to delayed neuronal
death.
Methods: We analyzed the behavior of neurons and microenvironment regulating cells using a contusion-induced
SCI model, examining early (3–6 h) to late times (14 d) after the injury.
Results: At the penumbra region close to the damaged core (P1) neurons and astrocytes underwent death in a
similar spatial and temporal pattern: both neurons and astrocytes died in the medial and ventral regions of the gray
matter between 12 to 24 h after SCI. Furthermore, mRNA and protein levels of transporters of glutamate (GLT-1)
and potassium (Kir4.1), functional markers of astrocytes, decreased at about the times that delayed neuronal death
occurred. However, at P1 region, ramified Iba-1+ resident microglia died earlier (3 to 6 h) than neurons (12 to 24 h),
and at the penumbra region farther from the damaged core (P2), neurons were healthy where microglia were
morphologically activated. In addition, round Iba-1/CD45-double positive monocyte-like cells appeared after
neurons had died, and expressed phagocytic markers, including mannose receptors, but rarely expressed
proinflammatory mediators.
Conclusion: Loss of astrocyte function may be more critical for delayed neuronal death than microglial activation
and monocyte infiltration.
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Background
In spinal cord injury (SCI), the primary damage is fol-
lowed by secondary damage that results in expansion of
the damaged area. Microenvironmental changes in the
spinal cord caused by primary damage can induce sec-
ondary damage [1,2]. Although resident microglia and
astrocytes, as well as blood leukocytes that infiltrate the
injured spinal cord, can be an important regulator of the
microenvironment, little is known about how these
microenvironment-regulating cells behave in early injury
states in response to SCI and whether they affect delayed
neuronal death.
Microglia, as resident immune cells of the brain and
spinal cord, scan their microenvironment and act as sen-
sors of pathological changes [3]. For several decades, it
has been generally accepted that, in response to injury or
inflammatory stimuli, microglia are activated and produce
cytotoxic proinflammatory mediators, such as tumor
necrosis factor (TNF)-α, inducible nitric oxide synthase
(iNOS), and reactive oxygen species (ROS) [4-6]. However,
recent studies of injured brains and spinal cords have
reported that microglia produce neuroprotective factors
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and increase phagocytic activity [7,8]. We also have
reported that microglia do not contribute to delayed neur-
onal death associated with lipopolysaccharide (LPS)- or
ATP-induced brain damage [9,10].
Astrocytes, the most abundant cells in the central ner-
vous system (CNS), are important microenvironment-
regulating cells. Astrocytes provide neurons with glucose
and neurotrophic factors, and protect neurons from oxida-
tive stress and excitotoxicity through glutathione (GSH)
production, glutamate and potassium uptake, and modula-
tion of water content [11-17]. Accordingly, it has been
reported that ablation of astrocytes augments traumatic
neuronal damage, and that transplantation of astrocytes
diminishes brain damage [18,19].
Blood leukocytes, including neutrophils and monocytes,
are other important players in the CNS inflammation.
Neutrophils infiltrate injured brain and spinal cord regions,
and produce neurotoxic effects by promoting the expres-
sion of iNOS, cyclooxygenase (COX)-2, and several cyto-
kines [10,20,21]. Monocytes infiltrate injured brain and
spinal cord regions. For monocytes, however, dual roles
have been reported: promoting clearance of the injured
area [22] and producing neurotoxic factors [9,23,24].
The aim of this study was to understand the discrete
roles of microenvironment-regulating cells in delayed
neuronal injury. Interestingly, we found that ramified
Iba-1+ cells (resident microglia) died earlier than neurons
in the area where delayed neuronal death occurred, and
that neurons were healthy where microglia were mor-
phologically activated. Round Iba-1+ cells that highly
expressed CD45 appeared after neurons had died, and
expressed phagocytic activity. Interestingly, the spatial
and temporal patterns of astrocyte and neuron death
were similar. Therefore, we suggest that Iba-1+ cells, in-
cluding ramified and round cells, are innocent in
delayed neuronal death, and speculate that loss of the




All experiments were performed in accordance with the
approved animal protocols and guidelines established by
the Ajou University School of Medicine Ethics Review
Committee, and all animal work was approved by the Eth-
ical Committee for Animal Research of Ajou University
(Amc-28).
Preparation of contusion-induced SCI
As previously described [25], female Sprague–Dawley rats
(200 to 250 g) were anesthetized using chloral hydrate
(360 mg/kg, i.p.), and a dorsal laminectomy was per-
formed at the ninth thoracic vertebra level (T9) to expose
the spinal cord. A mechanical force (150 kdyn, weight
diameter: 2 mm) was applied to the exposed spinal cord
using the Infinite Horizon Impactor (Precision Systems
and Instrumentation, Lexington, KY, USA). Rats that
received laminectomy alone were used as sham-operated
controls. Prior to sacrificing, from 3h to 14 d after surgery,
rats received postoperative care that included manual ex-
cretion of urine twice daily until bladder function
returned.
Tissue preparation
Rats were anesthetized and transcardially perfused with
a saline solution containing 0.5% sodium nitrate and
heparin (10 U/ml), and then with 4% paraformaldehyde
in 0.1 M phosphate buffer (PB) at pH 7.4 to fix tissues.
Spinal cords from T7 to T10 (about 9 to 11 mm length)
were removed (Figure 1D), post-fixed overnight at 4°C
in 4% paraformaldehyde, and stored at 4°C in a 30%
sucrose solution until they sank.
Longitudinal sections (30 μm thickness) and cross sec-
tions (30 μm thickness) of spinal cords were obtained
using a cryostat (Leica, Wetzlar, Germany). More than
300 cross sections were obtained from a spinal cord. Sec-
tions were attached to 30 to 35 slides in the way the first
section was attached to the first slide, and the second slide
was attached to the second slide, and so on. In this way,
each slides included 9 to 12 sections. To examine behavior
of neurons, astrocytes and microglia, three serial slides
that included immediately adjacent cross sections were
stained with antibodies specific for NeuN (a neuron mar-
ker), GFAP (an astrocyte marker), and Iba-1 (a microglia/
monocyte marker) (Additional file 1: Figure S1).
For reverse transcription-polymerase chain reaction
(RT-PCR), quantitative real-time PCR (q-PCR) and West-
ern blot analysis, spinal cord tissues (approximately 4 mm
total length around the contusion center) were obtained
without perfusion with 4% paraformaldehyde.
Measurement of damage areas
Longitudinal sections were stained with cresyl violet, a
Nissl stain. Stained sections were photographed using
an Olympus BX51 microscopy camera (Olympus,
Ballerup, Denmark). The damaged area was defined as
the area in which large Nissl+ neurons disappeared,
presented as lesion length [26,27]. Because the width of
gray matter in spinal cords varied among animals, it
was more accurate to measure length than area. To
measure lesion length using the public domain JAVA
image-processing program IMAGE J (http://rsb.info.
nih.gov/ij), we selected the horizontal section contain-
ing the maximum lesion, drew five lines from the top
to the bottom of the gray matter, and measured the dis-
tance of each line between the rostral and the caudal
area where Nissl+ neurons had disappeared as shown in
Figure 1B.
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Immunohistochemistry
For 3,3'-diaminobenzidine (DAB) staining, sections were
rinsed three times in phosphate-buffered saline (PBS)
and pretreated for five minutes with PBS containing 3%
H2O2. They were then rinsed with PBS containing 0.2%
Triton X-100 (PBST), blocked with PBST containing 1%
bovine serum albumen (BSA) for 30 minites, and incu-
bated for 2 h at room temperature with primary
Figure 1 Time-dependent gray matter damage in the contusion-induced SCI model. Contusion insult (150 kdyn) was applied to T9 of rat
spinal cords. Longitudinal sections (30 μm) were obtained from 6 h to 14 d after the injury. (A) Sections were stained with cresyl violet. Sham-
operated animals were employed as controls. In left panels, gray matter (G) was intensely stained with cresyl violet (compare to white matter, W).
Right panels (Area 1 and Area 2) are higher magnifications of Areas 1 and 2 indicated in the left panels. Large (black arrows) and small (white
arrows) Nissl+ cells are neurons and glial cells, respectively. At 7 d, many small Nissl+ cells (white arrowheads) appeared. Dotted white lines in the
left panel show the positions of Area 1 and Area 2 relative to the contusion sites. Black arrowheads: contusion sites. (B) The most damaged cresyl
violet-stained sections obtained at the indicated times were selected, and the extent of damage was evaluated by measuring the length of gray
matter, as described in Materials and Methods. Black arrowheads: contusion sites. (C) Graphic presentation of the values measured in (B). Values in
(C) are means ± SEMs of four to six animals. (D) Relative positions of contusion site (arrowhead at T9), primary damage site (epicenter), delayed
damage-occurring site (penumbra 1), and delayed damage-absent site (penumbra 2). Spinal cords between T7 and T10 were removed and
analyzed. Scale bars: 500 μm (left panel in A) and 25 μm (right panel in A). Data shown are representative of three independent experiments. In
each experiment, four to six animals were used for each time point.
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antibodies against CD45 (1:200; AbD Serotec, Oxford,
UK), CD68 (1:200; AbD Serotec), EAAT2 (GLT-1, 1:500;
Abcam, Cambridge, MA, USA), glial fibrillary acidic pro-
tein (GFAP, 1:300; Sigma, St. Louis, MO, USA), IL-1β
(1:200; R&D Systems, Minneapolis, MN, USA), iNOS
(1:200; abcam), ionized calcium binding adaptor mol-
ecule 1 (Iba-1, 1:1,000; Wako Pure Chemical Industries,
Osaka, Japan), Kir4.1 (1:200; Alomone Labs, Jerusalem,
Israel), mannose receptor (MR, 1:50; Abcam), or neuronal
nuclei (NeuN, 1:300; Chemicon, Temecula, CA, USA).
Sections were then rinsed in PBST, incubated with bioti-
nylated secondary antibodies (Vector Laboratories, Burlin-
game, CA, USA), visualized using 0.05% DAB and 0.003%
hydrogen peroxide in 0.1 M PB, and examined under a
bright-field microscope (Olympus Optical, Tokyo, Japan).
For double-immunofluorescence staining, sections were
dried for 1 h, washed twice in PBS, treated with 1% BSA
for 30 minutes, and then incubated with the appropriate
combination of antibodies against NeuN, Iba-1, GFAP,
iNOS, CD45, CD68 and mannose receptor. Immunoreac-
tive proteins were visualized using Alexa Fluor 488- or
Alexa Fluor 555-conjugated secondary antibodies (1:600
dilution; Invitrogen, Eugene, OR, USA). Cells were coun-
terstained with 4',6-diamidino-2-phenylindole (DAPI;
Vector Laboratories) to detect nuclei. Images were ana-
lyzed under a confocal microscope (LSM 510, Carl Zeiss,
Jena, Germany) or a florescence microscope (Carl Zeiss).
For cresyl violet (Sigma) staining, sections were rehy-
drated, placed in cresyl violet for 15 to 20 minutes, then
rinsed and dehydrated with a series of graded alcohols
(70% to 100%). Sections were placed in xylene and
mounted.
Terminal deoxynucleotidyl transferase-mediated
deoxyuridine triphosphate nick-end labeling (TUNEL)
assays
TUNEL assays were performed using the Apoptag Fluor-
escein In Situ Detection Kit (Intergen, Purchase, NY,
USA) according to the manufacturer’s instructions. Briefly,
spinal cord sections were post-fixed in pre-cooled
permeabilization solution (ethanol:acetic acid, 2:1) for five
minutes and incubated with TUNEL reaction mixture in a
humidified chamber at 37°C for one hour. After washing
with PBS, sections were incubated with anti-Iba-1 anti-
body for two hours, washed in PBS, and then incubated
with Texas Red-labeled secondary antibodies.
RT-PCR and q-PCR
Spinal cord tissues were dissected, after which total RNA
was isolated using RNAzol B (iNtRON, Sungnam, Korea)
and cDNA was prepared using Avian Myeloblastosis Virus
reverse transcriptase (Promega, Madison, WI, USA)
according to the manufacturer’s instructions using a
Corbett thermal cycler (Corbett Research, Sydney, NSW,
Australia). PCR was performed in a final volume of 25 μl
using HiQ Taq Red DNA Polymerase (GenDEPOT,
Barker, TX, USA) and a Corbett thermal cycler. The amp-
lified products were separated by electrophoresis on a
1.0% agarose gel, and detected under UV light. For q-
PCR, cDNA and forward/reverse primers (200 nM) were
added to 2x KAPA SYBR Fast Master Mix and reactions
were performed on an RG-6000 real-time amplification
instrument (Corbett Research). The threshold cycle num-
ber (Ct) of each target was calculated and expressed rela-
tive to that of GAPDH (glyceraldehyde-3-phosphate
dehydrogenase), used as a reference. Delta-delta Ct values
of targets were presented as relative fold induction. Pri-
mers (Bioneer, Daejeon, Korea) used in q-PCR/RT-PCR
are shown in Table 1.
Western blot analysis
Spinal cord tissues were dissected and homogenized in
modified RIPA buffer (50 mM Tris–HCl pH 7.4, 1%
NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM
Na3VO4, 1 mM NaF) containing protease inhibitors
(2 mM phenylmethylsulfonyl fluoride, 10 μg/ml leupeptin,
10 μg/ml pepstatin, 2 mM EDTA). Each lysate was centri-
fuged at 10,000 x g for 10 minutes at 4°C, and the super-
natants were collected. Proteins were separated by SDS-
PAGE, and transferred to a nitrocellulose membrane. The
membrane was incubated with primary antibodies against
iNOS (Upstate Biotechnology, Lake Placid, NY, USA),
COX-2 (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), or actin (Santa Cruz Biotechnology), followed by in-
cubation with horseradish peroxidase (HRP)-conjugated
secondary antibodies (Zymed Laboratories, San Francisco,
CA, USA) and visualization using an enhanced chemilu-
minescence system.
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Statistical analysis
Comparisons between two groups were analyzed using
Student’s t-test. Comparisons among multiple groups
were analyzed by one-way ANOVA followed by post hoc
Student–Newman–Keuls tests using the Statistical Pack-
age for Social Sciences 8.0 (SPSS Inc., Chicago, IL, USA).
Results
Microglia die earlier than neurons and astrocytes in the
penumbra region in SCI
In spinal cord injury (SCI), the primary damage is fol-
lowed by delayed secondary damage. However, it is still
ambiguous what causes delayed damage. Although inflam-
mation has been suggested as a cause of delayed neuronal
death in SCI, emerging evidence has suggested that
inflammation in acute injury also exerts beneficial effects
[28,29]. To address the cause of delayed neuronal death
and the controversy surrounding the role of inflammation
in the injured spinal cord, we analyzed the behavior of
neurons and other microenvironment regulating cells
using a contusion-induced SCI model, examining early
(6 h) to late times (14 d) after the injury. Using Nissl stain-
ing, we first examined time-dependent neuronal damage
in the gray matter of longitudinal sections of the spinal
cord between T7 and T10 after the weight-drop at T9
(Figure 1A, D). In Figure 1A, right panels (Area 1 and
Area 2) are higher magnifications of Areas 1 and 2 indi-
cated in the left panels. Dotted white lines in the left panel
show the positions of Area 1 and Area 2 relative to the
contusion sites (Figure 1A). In sham-operated spinal cords,
large Nissl+ neurons (black arrows in Figure 1Aa, b, c) and
small Nissl+ glial cells (white arrows in Figure 1Aa, b, c)
were detectable throughout the gray matter. Intact spinal
cords showed a pattern similar to that of sham-operated
spinal cords (data not shown). At areas near contusion sites
(black arrowheads in Figure 1Ad, g, j, m), a loss of large
Nissl+ cells was clearly evident within 6 h (Figure 1Ad, e).
The neuron-damage area increased between 12 h and 1 d
(Figure 1Ag vs. Figure 1Aj), but did not further increase
thereafter until 7 to 14 d (Figure 1Aj vs. Figure 1Am;
Figure 1C). Small Nissl+ cells detected at 7 d (white arrow-
heads in Figure 1An) appeared to be glia and/or infiltrated
blood cells, as shown in the following studies. We deter-
mined neuron-damage areas by measuring the length of
gray matter where large Nissl+ cells had disappeared at
five positions evenly divided from top to bottom, as shown
in Figure 1B. Since the extent and shape of gray matter
collapse due to contusion injury varied among animals,
we measured length instead of area. Using these measure-
ments, we plotted the time-dependence of death in areas
where neurons died (Figure 1C). Based on these measure-
ments, we designated the contusion center (approximately
2 mm) as the epicenter where neurons acutely died dir-
ectly due to the weight. In the penumbra region, the areas
where neurons underwent death between 12 h and 1 d
were designated as P1, and the areas where neurons were
healthy for up to 14 d as P2 (Figure 1C, D).
Next, we further examined time-dependent behavior
of neurons, astrocytes and microglia in immediately
adjacent cross sections using antibodies specific for
NeuN, GFAP, and Iba-1, respectively (Additional file 1:
Figure S1). Because neurons in rostral and caudal areas
showed similar delayed damage behavior (data not
shown), we here show caudal areas at dorsal (D), medial
(M), and ventral (V) areas (Figure 2). In intact spinal
cords, healthy dorsal neurons appeared as small, round
cell bodies and healthy ventral neurons appeared as
large, polygonal cell bodies (white arrowheads in
Figure 2A). Neurons in the medial region were larger
than those in dorsal regions but smaller than those in
the ventral region (white arrowheads in Figure 2A).
GFAP+ astrocytes exhibited very different morphologies
in intact dorsal, medial and ventral areas: in the dorsal
area, astrocytes were dense and had highly branched
processes, whereas astrocytes in the medial and ventral
region had long, thin processes (white arrows in
Figure 2A). Iba-1+ microglia, however, showed a highly
ramified morphology that was similar in all dorsal, med-
ial and ventral regions (black arrows in Figure 2A).
Morphologies of neurons, microglia and astrocytes in
sham-operated animals were the same as in intact ani-
mals (data not shown).
Immunostaining with specific markers of each type of
cell showed that in response to SCI, neurons as well as
astrocytes and microglia almost completely disappeared
within 6 h after the contusion injury in the ventral and
medial regions of the damage core (epicenter) (Figure 2B).
However, in dorsal regions, neurons, astrocytes and
microglia were healthy at 6 h (Figure 2B) and remained
healthy at 7 d (data not shown), although Iba-1+ microglia
lost their processes and exhibited an activated morphology
(black arrows in Figure 2B). The different behaviors of
neurons, astrocytes and microglia in dorsal and medial/
ventral areas could reflect differences in mechanical forces
applied to each area (ventral areas may function as a cush-
ion for dorsal areas) and/or difference in the vulnerability
of cells in each area.
An interesting finding was the behavior of Iba-1+ micro-
glia in the penumbra region close to the epicenter (P1 in
Additional file 1: Figure S1B, and Figure 2C). At 12 h after
SCI, Iba-1+ microglia in the medial and ventral areas were
dead and those in the dorsal area were morphologically
activated (black arrows in Figure 2C). Notably, neurons and
astrocytes were still alive in all areas in the adjacent serial
sections (Figure 2C), although astrocytes became hyper-
trophic (white arrows in Figure 2C). Double-labeling using
anti-NeuN and anti-Iba-1 antibodies confirmed these find-
ings. In intact spinal cords, neurons and microglia were
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healthy in all dorsal and ventral regions (Figure 3A, 3A’). In
the epicenter, neurons and microglia in the ventral areas
disappeared at 12 h, but were alive in the dorsal areas
(Figure 3B, B’). In the penumbra regions close to the epi-
center (P1), neurons in the dorsal and ventral areas were
still intact at 12 h (Figure 3C, C’) although microglia in the
ventral areas were not intact (Figure 3C, C’) as evidenced
by TUNEL staining of ventral microglia at 3-6 h after SCI
(Figure 3C”).
In analysis of cross sections obtained at 3 d, we could
not find any serial sections where neurons and astro-
cytes were alive but microglia disappeared in medial
and ventral areas, which was shown in P1 areas at 12 h
(Additional file 1: Figure S1B, and Figure 2C). We fur-
ther found that immunoreactivity of S100β (another
astrocyte marker) in P1 ventral areas also remained at
12 h, but decreased at 3 d (Additional file 2: Figure S2).
Therefore, neuron (and/or gray matter) and astrocyte
damage increased between 12 h and 3 d (arrowheads in
Additional file 1: Figure S1B) as shown in longitudinal
sections (Figure 1). In addition, round Iba-1+ cells
appeared in the medial and ventral areas where rami-
fied resident microglia disappeared (black arrows in
Figure 2C). In the dorsal areas, round and/or rod-
shaped Iba-1+ cells were also detectable (black arrows
in Figure 2C). In subsequent experiments, we found
Figure 2 Time-dependent behavior of neurons, resident microglia, and astrocytes in injured spinal cords. Cross sections (30 μm) were
obtained from the intact spinal cord (A), epicenter (Epi, B), P1 (C), and P2 (D) areas in the caudal direction at the indicated times after injury. The
behaviors of neurons (white arrowheads), astrocytes (white arrows), and resident microglia/monocytes (black arrows) were compared by staining
immediately adjacent serial sections with antibodies against NeuN, GFAP, and Iba-1, respectively, and then visualizing using HRP-conjugated
secondary antibodies. Dorsal (D), medial (M), and ventral (V) areas were magnified in the lower panels. Data shown are representative of more
than three independent experiments. In each experiment, at least five animals were used for each time point. Scale bar: 200 μm (upper panels),
50 μm (lower panels).
Min et al. Journal of Neuroinflammation 2012, 9:100 Page 6 of 13
http://www.jneuroinflammation.com/content/9/1/100
that these round Iba-1+ cells were labeled with CD45
unlikely ramified Iba-1+ cells in intact spinal cord (see
Figure 4A).
It is also noteworthy that, in the P2 penumbra region
farther from the epicenter than the P1 region, microglia
were morphologically activated at 12 h and 3 d (black
arrows in Figure 2D), but neurons and astrocytes were still
healthy (Figure 2D). In the P2 region, astrocytes became
transiently hypertrophic at 12 h (white arrows in
Figure 2D). Thus, astrocytes at 3 d were similar to that in
the intact spinal cord (white arrows in Figure 2D). Taken
together, these results suggest that microglia are innocent
in delayed neuronal death in SCI: microglia died earlier
than neurons in the P1 region, and neurons were healthy
in the P2 region where microglia were activated. Further-
more, it is noticeable that the time course of the disappear-
ance of astrocytes in P1 ventral areas coincided with that
of neuronal death in these areas. We further examined
correlation between death of neurons and astrocytes in
Figure 5.
Iba-1+/CD45+ cells appear in injured spinal cord and exhibit
phagocytic activity
In P1 medial and ventral regions, round Iba-1+ cells were
found at 3 d after SCI although ramified microglia died at
3 to 6 h (Figure 2C, 3 d vs. 12 h, and see Figure 3C”). In
experiments to analyze the round Iba-1+ cells, we found
that these cells expressed CD45, a marker of microglia
and monocytes [30,31] unlike ramified resident microglia
that expressed Iba-1 but not CD45 (see Figure 4A). The
CD45+ cells were barely detectable at 12 h, and a few were
found at 1 d (white arrows in Figure 4B). The numbers of
CD45+ cells increased at 3 and 7 d (white arrows in
Figure 4B). In dorsal areas, CD45+ cells were detectable,
but there were fewer CD45+ cells in these areas at all time
points than in ventral and medial areas (Figure 4B). In
addition, at 7 d, CD45+ cells in the dorsal area had
adopted a ramified morphology similar to that of activated
microglia (black arrows in Figure 4B), whereas those in
the ventral and medial areas maintained a round shape
(white arrows in Figure 4B). In the epicenter (the damage
Figure 3 Microglial behavior in SCI is not correlated with neuronal death. Cross sections were obtained from the intact spinal cord (A, A’),
epicenter (B, B’), and P1 regions (C, C’, C”) in the caudal direction at the indicated times after injury, and double-stained with anti-NeuN and
anti-Iba-1 antibodies. NeuN and Iba-1 immunopositive regions were visualized with Alexa 488 (green)- and Alexa 555 (red)-conjugated secondary
antibodies, respectively. (A’-C’) Higher magnification images of boxed regions in panels (A-C). (C”) Cross sections from the P1 regions were
stained with TUNEL (green) and Iba-1 (red). Nuclei were counterstained with DAPI. Scale bars: 100 μm (A), 20 μm (A’) and 10 μm (C”). Data shown
are representative of at least three independent experiments.
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core), CD45+ cells showed a behavior similar to that in P1
areas (data not shown). However, in the P2 region where
neither neurons nor astrocytes were injured, CD45+ cells
were not detectable at any time points (Figure 4B). Collect-
ively, these results indicate that round Iba-1+/CD45+ cells
appeared in the injured spinal cord and filled the area
where ramified Iba-1+ resident microglia and neurons had
died.
We next examined the expression of several inflamma-
tory mediators in injured spinal cords. Interestingly, both
mRNA and protein levels of the major proinflammatory
mediators, IL-1β, IL-6, iNOS and COX-2, increased and
then decreased before CD45+ cells appeared in the injured
spinal cord. RT-PCR analysis indicated that IL-1β, IL-6,
iNOS, and COX-2 mRNA levels were increased within 3
to 6 h after SCI, remained elevated for up to 1 d, and
decreased at 3 d (Figure 4C). Protein expression of iNOS
and COX-2 was also detectable between 12 h and 1 d
(Figure 4D). Accordingly, neither iNOS nor IL-1β pro-
tein was detectable immunohistochemically in the gray
matter of injured spinal cords at 1 to 7 d (Figure 4E). Al-
though IL-1β protein was detected in morphologically
activated microglia in the P2 area at 12 h (Additional file
3: Figure S3), delayed neuronal death did not occur in
this area. Moreover, iNOS was detected in neutrophils
at 1 d after SCI (Additional file 4: Figure S4) as previ-
ously des- cribed by others [32].
Next, we examined the possibility that these Iba-1+/
CD45+ cells exhibited phagocytic activity (31). Therefore,
we examined whether Iba-1+/CD45+ cells expressed CD68
and mannose receptor (MR) that are involved in the repair
process by engulfing damaged cells and debris [33,34].
MR expression was detectable at 7 d (Figure 4E). CD68
expression was detectable at 3 d and further increased
at 7 d. In double-labeling experiments using combina-
tions of Iba-1/CD68 or CD45/MR antibodies (raised in
Figure 4 Iba-1+/CD45+ cells appear and express phagocytic activity in injured spinal cords. (A, B, E, F) Sections from intact, P1, or P2
regions at the indicated times after the injury were labeled with indicated antibodies. White arrows indicated positively labeled cells with each
antibody. (B) Black arrows (P1, 7 d) indicated CD45+ cells that are not round. (C, D) Spinal cord tissues were obtained at the indicated times after
SCI, and total RNA and protein were prepared and analyzed by RT-PCR (C) and Western blotting (D), respectively, as described in Materials and
methods. Data shown are representative of at least three independent experiments. Scale bars: 20 μm.
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different species), CD68 and MR immunoreactivity were
detected in Iba-1+ and CD45+ cells, respectively
(Figure 4F). Taken together, these results suggest that,
instead of causing delayed neuronal death in SCI, Iba-
1+/CD45+ cells function to clean up the damaged spinal
cord.
The temporal and spatial patterns of astrocyte loss are
coincident with those of neuron loss
It is well known that astrocytes maintain the homeo-
stasis of extracellular glutamate and potassium; they
also scavenge ROS, produce growth factors and pre-
vent excessive inflammation [35-40]. Since astrocytes
disappeared in P1 medial and ventral areas at times
similar to those when the disappearance of neurons
was noted (Figure 2), we further evaluated the spatial
and temporal relationship between the deaths of neu-
rons and astrocytes by double-label immunohisto-
chemistry using antibodies against NeuN and GFAP. In
intact spinal cords, neurons and astrocytes were
healthy in all dorsal and ventral regions (Figure 5A).
As we expected, in the P1 region at 12 h after SCI, neu-
rons and astrocytes were healthy in all dorsal and ven-
tral areas (Figure 5A). However, in the P1 region at 18
h (at 18 to 24 h depending on animals), neurons and
astrocytes became undetectable in ventral areas
Figure 5 Loss of astrocytes and reduced expression of GLT-1 and Kir4.1 in injured spinal cords. (A, D) Sections from intact and P1 areas
at the indicated times after injury were stained with NeuN/GFAP (A), and GLT-1 or Kir4.1 (D) antibodies. Right panels in (A) and lower panels in
(D) are higher magnification images of indicated regions in the left and upper panels, respectively. (B, C) Spinal cord tissues (2 mm in length
around the contusion center) were obtained at the indicated times after SCI, and total RNA was prepared and analyzed by RT-PCR (B) or q-PCR
(C) as described in Materials and Methods. Values in (C) are means ± SEMs of five animals. (D) The white arrow represents neuronal cell body-like
morphology. Data shown are representative of three independent experiments. Scale bars: 200 μm (left panels in A and upper panels in D), 10
μm (right panels in A), and 50 μm (lower panels in D).
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whereas both cell types were healthy in dorsal areas
(Figure 5A).
We further examined time-dependent changes in the
mRNA levels of transporters of glutamate (GLT-1) and
potassium (Kir4.1) that are expressed in astrocytes
[16,17]. SCI increases extracellular K+ and glutamate
owing to the release of intracellular K+ and glutamate
from damaged cells [41-43]. Therefore, surrounding
neurons could be damaged if Kir4.1 and/or GLT-1 do
not function properly [16,17,44,45]. RT-PCR and q-PCR
revealed significant reductions in GLT-1 mRNA levels at
3 and 12 h after SCI, and Kir4.1 mRNA levels at 12 and
72 h after SCI (Figure 5B, C). In immunohistochemistry,
similar results were obtained (Figure 5D). In intact
spinal cords, GLT-1 was evenly expressed in the dorsal,
medial, and ventral areas in the gray matter (Figure 5D:
lower panels are higher magnifications of indicated areas
in the upper panels). Kir4.1 also evenly expressed in the
all areas in the gray matter except neuronal cell bodies
(white arrow in Figure 5D). However, at 14 h after SCI,
immunoreactivities of both GLT-1 and Kir4.1 were
reduced in the medial and ventral areas while main-
tained in the dorsal areas (Figure 5D). These results sug-
gest that loss of astrocytes and/or astrocyte function
results in the loss of homeostasis of extracellular glutam-
ate and potassium, which may contribute to delayed
neuronal death.
Discussion
The major findings in this study are as follows: First, there
is no evident connection between microglial activation
and delayed neuronal death. In the P1 region, microglia
died earlier than neurons; and in the P2 region where
microglia were morphologically activated, neurons were
healthy. Second, Iba-1+/CD45+ cells appeared where neu-
rons and microglia had died, and expressed phagocytic
activity. Third, astrocyte death and/or loss of function oc-
curred with a temporal and spatial pattern similar to that
of delayed neuronal death.
It has been generally accepted that microglia are activated
in brain/spinal cord injury and aggravate the injury. How-
ever, in previous studies, we and others have reported that
inflammatory responses are very different between cultured
microglia and microglia in the brain. Purified cultured
microglia produce neurotoxic inflammatory mediators,
such as iNOS and TNF-α, in response to inflammatory sti-
mulators, including LPS, thrombin and interferon-γ [4-6].
However, in the LPS- or ATP-injected brain, and in the
ischemic brain, microglia barely express these inflammatory
mediators, and are more vulnerable to injury than are neu-
rons [9,10,21]. This is partly due to the fact that, in the
brain, astrocytes inhibit inflammatory responses [39,40].
Furthermore, cerebrospinal fluid is continuously pro-
duced and circulates [46], a process that removes
endogenously produced inflammatory stimulators. In
addition, recent studies have reported that activated
microglia exert neuroprotective actions through produc-
tion of neurotrophic factors and increase in phagocytic
activity [28,29,47-49]. The results obtained in the current
study also suggest that microglia do not play a cytotoxic
role in delayed neuronal damage after SCI: microglia
underwent death somewhat earlier than neurons in P1
ventral regions (Figures 2C, and 3C, C’ C”). Furthermore,
at P1 dorsal and P2 dorsal/ventral regions, neurons were
healthy, although they were surrounded by Iba-1+ cells
with an activated morphology (Figures 2C, D and 3B C).
Expression of the inflammatory mediators, IL-1β, IL-6,
iNOS and/or COX-2, was detectable at the mRNA level 3
to 24 h following SCI, and at the protein level after 12
to 24 h (Figure 4C, D), as previously reported by others
[50-52]. However, neurotoxic iNOS [53] was detected in
neutrophils in damaged areas (Additional file 4: Figure
S4). Although IL-1β was detected in morphologically acti-
vated microglia in the P2 region (Additional file 3: Figure
S3), we have previously found that high levels of IL-1β
expressed in microglia do not promote neurotoxicity [9].
Collectively, these observations suggest that microglia
may not be neurotoxic in the injured spinal cord.
Several studies have reported that monocytes infiltrate
from the blood to the injured spinal cord [54]. Iba-1 is
highly expressed in both monocytes and microglia; these
two types of cells can be discriminated on the basis of
CD45 expression levels. CD45 is highly expressed in mono-
cytes but only weakly in microglia [9,30,31]. Iba-1+/CD45+
cells were not detectable in intact spinal cords, but were de-
tectable in P1 ventral and medial areas beginning at 12 h,
increased at 1 d, and peaked at 3 and 7 d (Figure 4A, B),
which is later than the times of neuronal death in P1
(Figures 2C and 4B). A more important finding is that these
Iba-1+/CD45+ cells in P1 regions expressed CD68 and MR,
indicators of phagocytic activity [33,34], rather than proin-
flammatory iNOS and IL-1β (Figure 4E, F). Although we
could not exclude the possibility that ramified Iba-1+
microglia changed into round Iba-1+/CD45+ cells, the
round Iba-1+/CD45+ cells could be monocytes infiltrated
from the blood.
It has been reported that monocytes/macrophages
express two different phenotypes: classically activated and
alternatively activated. Classically activated monocytes
exert a microbicidal effect through expression of pro-
inflammatory mediators, whereas alternatively activated
monocytes participate in the repair of damaged tissues
through expression of phagocytic activity [34]. Therefore,
monocytes could play complex roles in damaged tissues
[55]. Accordingly, some studies have reported that mono-
cytes infiltrated into injured brain and spinal cord play
neurotoxic roles [56,57], but other studies have reported
that monocytes regenerate injured axons and play
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important roles in recovery after SCI [55,58]. The results
in the study suggest that Iba-1+/CD45+ monocytes and/or
microglia detected at 3 and 7 d after SCI function to re-
move cell debris and repair injured tissues.
Finally, we found that the spatial and temporal patterns
of astrocyte and neuronal death were similar (Figures 2
and 5). GFAP and S100β immunoreactivity in P1 ventral
regions was detectable at 12 h, but not at 18 h or there-
after (Figures 2 and 5, Additional file 2: Figure S2). mRNA
levels of GLT-1 decreased at 3 and 12 h, and those of
Kir4.1 decreased at 12 and 24 h (Figure 5B, C). In immu-
nohistochemistry, GLT-1 and Kir4.1 levels decreased in
the medial and ventral areas but not in the dorsal areas at
14 h (Figure 5D). At 3 d, GLT-1, and Kir4.1 as well as
GFAP and S100β disappeared in P1 ventral regions as in
epicenter (Additional file 2: Figure S2A-D). Therefore, loss
of the supportive roles of astrocytes could contribute to
delayed neuronal death. Astrocytes actively function to
maintain brain homeostasis as well as to provide growth
factors and nutrients [11-15]. The transporters of glutam-
ate (EAAT1/GLAST and EAAT2/GLT-1) and potassium
(Kir4.1) are mainly expressed in astrocytes, and modulate
extracellular glutamate and potassium concentration,
respectively [17,44,59,60]. Since increase in extracellular
glutamate evokes neuronal excitotoxicity [44], abnormal
glutamate uptake increases neuronal death [17,44,61]. The
latest research has reported that reduced GLT-1 expression
aggravated SCI [62]. Dysfunction of glutamate transporters
is also associated with neurodegenerative diseases, such as
amyotrophic lateral sclerosis (ALS) and Huntington’s dis-
ease [63,64]. In addition, increase in extracellular K+ also
induces neuronal death through calcium influx and excito-
toxicity [65]. In the SOD1(G93A) ALS mice, a progressive
decrease in Kir4.1 expression was observed in the ventral
horn in pre-symptomatic stages [66]. In Kir4.1−/− mice,
hair cells and spiral ganglion neurons degenerated [67]. In
this study, we found that the spatial and temporal patterns
of astrocyte and neuronal death were similar (Figures 2
and 5). Furthermore, mRNA levels of GLT-1 decreased at
3 and 12 h, and those of Kir4.1 decreased at 12 and 24 h
(Figure 5B, C). In immunohistochemistry, GLT-1 and
Kir4.1 expression decreased in the medial and ventral areas
where neuronal death occurred (Figure 5D). The spatial
and temporal correlation between neuron and astrocyte
damage was also found in ATP-, NMDA- and kainic acid-
injected brain cortexes (Unpublished observation). In-
jection of ATP or NMDA into the brain induced acute
damage (3 h) to neurons and astrocytes and did not
cause a further increase at later times (3 and/or 7 d).
However, in kainic acid-injected brains, neuron and
astrocyte damage progressively increased from 3 h to 7
d. Furthermore, in all three injection models, neuron-
damage areas corresponded to astrocyte-damage areas
(Unpublished observation). Potential support for this
interpretation is provided by a recent report that trans-
plantation of human astrocytes facilitates functional re-
covery after SCI [68]. Thus, we speculate that astrocyte
death and/or loss of astrocyte function could be at least
a factor in the induction of neuronal death. A potential
important focus of future studies is determining
whether preservation of astrocytes might protect neu-
rons and prevent delayed neuronal death in SCI.
Conclusion
In SCI, inflammation has been considered as a cause of
delayed neuronal damage. However, inflammation appears
to function to remove cell debris and repair injured tis-
sues. Thus, loss of supportive function of astrocytes may
be critical for delayed neuronal death in SCI.
Additional files
Additional file 1: Figure S1. Preparation and analysis of cross section of
contusion-induced spinal cords. Description: Spinal cords between T7
and T10 were removed. About 300 cross sections (30 μm) from rostral to
caudal direction were prepared using a cryostat. (A) Sections were
attached to 30 to 35 slides as in the first slide, and the second slide was
attached to the second slide, and so on. In this way, each slides included
9 to 12 sections. (B) Three slides that included immediately adjacent
sections obtained at 12 h and 3 d after the injury were stained with
antibodies specific for NeuN, GFAP, and lba-1, respectively. Images were
taken and arranged from rostral to caudal. Arrowheads at 12 h and 3 d
indicate the section where neurons were damaged in the ventral areas.
Asterisks(*) at 12 h indicate the section where NeuN+ neurons and GFAP+
astrocytes were alive but lba-1+ microglia died in the ventral areas. Epi,
epicenter, P1, penumbra 1; P2, penumbra 2. Scale bar: 500 μm.
Additional file 2: Figure S2. Time dependent changes in expression of
astrocyte markers in SCI. Description: Serial slides including adjacent
section were stained with the antibodies specific for GFAP (A), S100β (B;
1:800, Swant Bellinzona, Switzerland), GLT-1 (C), and Kir4. 1 (D). Lower
panels are higher magnification image of indicated regions in upper
panels. Scale bar; 200 μm (upper panel), 50 μm (lower panel).
Additional file 3: Figure S3. IL-1β protein was detected in
morphologically activated microglia in the P2 area. Description: Sections
were obtained from intact and P2 areas at 12h after SCI, stained with IL-
1β antibodies, and visualized using HRP-conjugated secondary
antibodies. Scale bar: 100 μm and 20 μm (inset).
Additional file 4: Figure S4. iNOS was detected in neutrophils in
injured spinal cords. Description: (A) Sections were obtained at the
indicated times after SCI and stained with myeloperoxidase (MPO, a
neutrophil marker) antibodies and visualized with HRP-conjugated
secondary antibodies. (B) Sections obtained at 1 d after SCI were stained
with MPO/iNOS, and then visualized with Alexa 555 (red)-, and Alexa 488
(green)-conjugated secondary antibodies. Nuclei were counterstained
with DAPI. Scale bars: 20 μm.
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